You are here

  • Home
  • Archive
  • Volume 76, Issue 12
  • Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gaujoux-Viala C, Rincheval N, Dougados M, et al
Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort
Annals of the Rheumatic Diseases 2017;76:2054-2060.